(EN) The present disclosure includes a cancer peptide vaccine that contains a peptide of the sequence Asn-Val-Leu-His-Phe-Phe-Asn-Ala-Pro-Leu (SEQ ID NO: 1), a peptide of the sequence Ala-Ser-Leu-Asp-Ser-Asp-Pro-Trp-Val (SEQ ID NO: 2), a peptide of the sequence Lys-Leu-Lys-His-Tyr-Gly-Pro-Gly-Trp-Val (SEQ ID NO: 3), and a peptide of the sequence Leu-Leu-Gln-Ala-Glu-Ala-Pro-Arg-Leu (SEQ ID NO: 4), a method for producing the same, and the like.
(FR) La présente divulgation comprend un vaccin peptidique contre le cancer qui contient un peptide ayant la séquence Asn-Val-Leu-His-Phe-Phe-Asn-Ala-Pro-Leu (SEQ ID NO : 1), un peptide ayant la séquence Ala-Ser-Leu-Asp-Ser-Asp-Pro-Trp-Val (SEQ ID NO : 2), un peptide ayant la séquence Lys-Leu-Lys-His-Tyr-Gly-Pro-Gly-Trp-Val (SEQ ID NO : 3) et un peptide ayant la séquence Leu-Leu-Gln-Ala-Glu-Ala-Pro-Arg-Leu (SEQ ID NO : 4), son procédé de production et analogues.
(JA) 本開示は、Asn-Val-Leu-His-Phe-Phe-Asn-Ala-Pro-Leu(配列番号1)のペプチド、Ala-Ser-Leu-Asp-Ser-Asp-Pro-Trp-Val(配列番号2)のペプチド、Lys-Leu-Lys-His-Tyr-Gly-Pro-Gly-Trp-Val(配列番号3)のペプチド、およびLeu-Leu-Gln-Ala-Glu-Ala-Pro-Arg-Leu(配列番号4)のペプチドを含むがんペプチドワクチン、およびその製造方法などを含む。